Xiao Dong Yang
Founder at Apexigen America, Inc.
Network origin in Xiao Dong Yang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
16
| Public Company | Pharmaceuticals: Major | 16 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 12 | |
| Public Company | Miscellaneous Commercial Services | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xiao Dong Yang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Director/Board Member President Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Private Equity Investor | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer | |
| Michigan State University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| New York University | College/University | Doctorate Degree Graduate Degree | |
Refuge Biotechnologies, Inc.
 Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor General Counsel | |
| G.D. Searle LLC | Corporate Officer/Principal General Counsel | ||
| Indiana University | College/University | Doctorate Degree Doctorate Degree | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| Amherst College | College/University | Undergraduate Degree | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
| The University of Southampton | College/University | Undergraduate Degree | |
| The University of Manchester | College/University | Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member | |
W.M. Keck Foundation, Inc.
 W.M. Keck Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services W.M. Keck Foundation, Inc. is a charitable foundation which supports scientific, engineering, and medical research. The company was founded by William Myron Keck in 1954 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| BOEING | Aerospace & Defense | Director/Board Member |
Statistics
International
| United States | 41 |
| Canada | 5 |
| United Kingdom | 3 |
| Switzerland | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Commercial Services | 8 |
| Retail Trade | 2 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 276 |
| Corporate Officer/Principal | 137 |
| Chairman | 68 |
| Independent Dir/Board Member | 62 |
| Director of Finance/CFO | 41 |
Most connected contacts
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| James Topper | 49 |
| Iain Ross | 41 |
| David Parkinson | 31 |
| David Goeddel | 27 |
| Daniel Zabrowski | 23 |
| William J. Rutter | 22 |
| Scott Smith | 21 |
| Gordon Ringold | 20 |
| David Mack | 19 |
| Sam Wertheimer | 17 |
| Meenu Chhabra Karson | 17 |
| Linda Rubinstein | 16 |
| David Chang | 16 |
| Robert Bradway | 14 |
- Stock Market
- Insiders
- Xiao Dong Yang
- Company connections
